Isorhapontigenin ameliorates cerebral ischemia/reperfusion injury via modulating Kinase Cε/Nrf2/HO-1 signaling pathway,Brain and Behavior

当前位置： X-MOL 学术 › Brain Behav. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Isorhapontigenin ameliorates cerebral ischemia/reperfusion injury via modulating Kinase Cε/Nrf2/HO-1 signaling pathway
Brain and Behavior ( IF 3.1 ) Pub Date : 2021-06-08 , DOI: 10.1002/brb3.2143
Zhe Xue _{1,

2} , Kai Zhao _{1,

2} , Zhenghui Sun _{1,

2} , Chen Wu _{1,

2} , Bowen Yu _{1,

2} , Dongsheng Kong _{1,

2} , Bainan Xu _{1,

2}

Affiliation

Isorhapontigenin (ISO) has been shown to have antioxidant activity. This study aimed to investigate the antioxidant effects of ISO on cerebral ischemia/reperfusion (I/R) injury and its possible molecular mechanisms.

中文翻译：